Industry Experience

Director and Counsel

UBS, New York Branch

Lily represents public and private companies in strategic collaborations, complex product licensing, research and development, and distribution and co-promotion agreements. She advises early stage start-ups, generics manufacturers, and international pharmaceutical corporations, and assists clients in the negotiation of clinical and commercial manufacturing and supply chain agreements for both small molecules and biologics.

experience +

experience –

Prior to joining Faber, Lily was Director and Counsel at the New York Branch of UBS where she represented the bank in connection with domestic and international syndicated loan and complex financings.

Lily began her legal career as a member of the business transactions group of Sidley Austin. She then joined Simpson Thacher & Bartlett as an associate in the corporate department, focusing on international banking and finance transactions.

Recent Client Work +

Recent Client WOrk –

  • ‍Manufacturing and supply documentation for Atara Biotherapeutics’ exclusive license of clinical-stage T-cell therapy technology from Memorial Sloan Kettering Cancer Center
  • Exclusive worldwide license and collaboration agreement between Gilead Sciences, Inc. and GlobeImmune, Inc. for the development and commercialization of therapeutic vaccine products for use in conjunction with oral therapies for the treatment of chronic hepatitis B virus (HBV) infection
  • Exclusive in-license of QRxPharma’s dual-opioid pain product, MoxDuo IR, by international generic pharmaceuticals company, Actavis Group’s, U.S. subsidiary, Actavis, Inc.
  • Representation of a privately held pharmaceutical company in a development and manufacturing transaction with a U.S. manufacturing company for the clinical development and manufacture of drugs for the U.S. market designed to treat several serious infections affecting women’s health
  • Commercial supply chain documentation for an early stage, public biopharmaceutical company involved in the development of molecularly targeted product candidates and T-cell product candidates
  • ‍Commercial supply chain documentation for a late-stage, privately held biopharmaceutical company developing innovative medicines for serious women’s health infections

Community +

Community –

Lily is involved the following professional and community organizations:

  • Harvard Law School Women’s Association of New York
  • Montclair, New Jersey Township’s Advisory Committee for People with Disabilities, whose mission includes recommending programs, policies and legislation that benefit individuals with disabilities to the Township Council of Montclair
Bar Admissions
  • New York
  • ‍Harvard Law School, J.D.
  • University of Minnesota, B.A., summa cum laude, Phi Beta Kappa
  • Spanish